Lower dose of monkeypox vaccine is found to be safe with equal six-week antibody response, promising for vaccination strategies.
US regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to “administrative constraints” at the Food and Drug Administration, the company said.
This was used as a dose-saving strategy as supplies were initially limited. The vaccine has been shown to be efficacious in studies using real-world data from the 2022 and onward outbreak among ...
opens new tab respiratory syncytial virus (RSV) vaccine due to some "administrative constraints" and will complete the review ...
KINSHASA, Congo (AP) — Congo is struggling to contain its biggest mpox outbreak, and scientists say a new form of the disease ...
World Immunization Week: 507 vaccines in late-stage development, 88 using mRNA tech to prevent TB, malaria, flu, COVID-19, ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
On Sept. 28, Pfizer provided the FDA with safety and efficacy data for a lower-dose version of its vaccine meant for 5- to 11-year-olds, and said it plans to formally ask for emergency-use ...
A new strain of the monkeypox ... not millions, of doses. The effectiveness of these vaccines against clade Ib remains unknown, although animal data is promising. Researchers are also conducting ...
This is a study of a vaccine approved by the U.S. Food and Drug Administration (FDA) for adults to prevent monkeypox, now called mpox ... approved the use of two (0.5 mL) doses of JYNNEOS given ...
(RTTNews) - Moderna, Inc. (MRNA) announced Friday that the U.S. Food and Drug Administration's review of the Biologics License Application or BLA for mRNA-1345, its investigational respiratory ...
“An additional vaccine dose can provide added protection that may have decreased over time for those at highest risk,” she said. Unlike previous rounds of the vaccine, the Food and Drug Administration ...